
|Articles|April 27, 2021
Red Blood Cell Contaminants: Upstream Mitigation for Downstream Success
Author(s)BioIVT
When isolating peripheral blood mononuclear cells (PBMCs) from whole blood, red blood cell (RBC) contamination can have a significant impact on your downstream results. In this white paper, learn the sources of RBC contamination, the downstream impact of RBC contamination and mitigation strategies that will improve your results.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Top 10 BioPharm International Articles of 2025
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
5